• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性缺血性中风后循环内皮祖细胞的增加与良好预后相关。

The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome.

作者信息

Sobrino Tomás, Hurtado Olivia, Moro María Angeles, Rodríguez-Yáñez Manuel, Castellanos Mar, Brea David, Moldes Octavio, Blanco Miguel, Arenillas Juan F, Leira Rogelio, Dávalos Antonio, Lizasoain Ignacio, Castillo José

机构信息

Clinical Neuroscience Research Laboratory, Department of Neurology, Hospital Clínico Universitario, University of Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Stroke. 2007 Oct;38(10):2759-64. doi: 10.1161/STROKEAHA.107.484386. Epub 2007 Aug 30.

DOI:10.1161/STROKEAHA.107.484386
PMID:17761925
Abstract

BACKGROUND AND PURPOSE

Increased circulating endothelial progenitor cells (EPC) have been associated with a low cardiovascular risk and may be involved in endothelial cell regeneration. The present study was designed to evaluate the prognostic value of EPC in acute ischemic stroke.

METHODS

Forty-eight patients with a first-ever nonlacunar ischemic stroke were prospectively included in the study within 12 hours of symptoms onset. Stroke severity was evaluated by the National Institutes of Health Stroke Scale, and functional outcome was assessed at 3 months by the modified Rankin Scale (mRS). Infarct volume growth between admission and days 4 to 7 was measured on multiparametric MRI. EPC colonies were defined as early outgrowth colony-forming unit-endothelial cell (CFU-EC). The increment of CFU-EC was quantified during the first week and defined as the absolute difference between the number of CFU-EC at day 7 and admission. The influence of CFU-EC increase on good functional outcome (mRS <or=2) and infarct growth was analyzed by logistic regression and linear models.

RESULTS

Patients with good outcome (n=25) showed a higher CFU-EC increment during the first week (median [quartiles], 23 [11, 36] versus -3 [-7, 1], P<0.0001) compared with patients with poor outcome. CFU-EC increment >or=4 during the first week was associated with good functional outcome at 3 months (odds ratio, 30.7; 95% CI, 2.4 to 375.7; P=0.004) after adjustment for baseline stroke severity, ischemic volume and thrombolytic treatment. For each unit increase in the CFU-EC the mean reduction in the growth of infarct volume was 0.39 (0.03 to 0.76) mL (P=0.033).

CONCLUSIONS

The increase of circulating EPC after acute ischemic stroke is associated with good functional outcome and reduced infarct growth. These findings suggest that EPC might participate in neurorepair after ischemic stroke.

摘要

背景与目的

循环内皮祖细胞(EPC)数量增加与较低的心血管风险相关,且可能参与内皮细胞再生。本研究旨在评估EPC在急性缺血性卒中中的预后价值。

方法

48例首次发生的非腔隙性缺血性卒中患者在症状发作后12小时内被前瞻性纳入研究。采用美国国立卫生研究院卒中量表评估卒中严重程度,在3个月时用改良Rankin量表(mRS)评估功能结局。在多参数磁共振成像上测量入院时与第4至7天之间梗死体积的增长。EPC集落被定义为早期生长的集落形成单位内皮细胞(CFU-EC)。在第一周内对CFU-EC的增量进行量化,定义为第7天与入院时CFU-EC数量的绝对差值。通过逻辑回归和线性模型分析CFU-EC增加对良好功能结局(mRS≤2)和梗死生长的影响。

结果

与预后不良的患者相比,预后良好的患者(n=25)在第一周内CFU-EC的增量更高(中位数[四分位数],23[11,36]对-3[-7,1],P<0.0001)。在调整基线卒中严重程度、缺血体积和溶栓治疗后,第一周内CFU-EC增量≥4与3个月时良好的功能结局相关(优势比,30.7;95%可信区间,2.4至375.7;P=0.004)。CFU-EC每增加一个单位,梗死体积增长的平均减少量为0.39(0.03至0.76)mL(P=0.033)。

结论

急性缺血性卒中后循环EPC的增加与良好的功能结局和梗死生长减少相关。这些发现提示EPC可能参与缺血性卒中后的神经修复。

相似文献

1
The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome.急性缺血性中风后循环内皮祖细胞的增加与良好预后相关。
Stroke. 2007 Oct;38(10):2759-64. doi: 10.1161/STROKEAHA.107.484386. Epub 2007 Aug 30.
2
CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke.胞磷胆碱治疗可增加急性缺血性卒中患者循环中的内皮祖细胞。
Neurol Res. 2011 Jul;33(6):572-7. doi: 10.1179/016164110X12807570510176.
3
Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke.与人类缺血性中风相关的循环内皮祖细胞的分子特征的时间进程。
J Neurosci Res. 2012 Sep;90(9):1788-93. doi: 10.1002/jnr.23068. Epub 2012 Apr 19.
4
Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase.他汀类药物治疗急性缺血性脑卒中患者循环内皮祖细胞水平升高。
Eur J Neurol. 2012 Dec;19(12):1539-46. doi: 10.1111/j.1468-1331.2012.03770.x. Epub 2012 May 28.
5
Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke.循环内皮祖细胞作为急性脑卒中内皮功能障碍或修复的新标志物。
Stroke. 2008 May;39(5):1441-7. doi: 10.1161/STROKEAHA.107.499236. Epub 2008 Mar 20.
6
Early infarct growth predicts long-term clinical outcome in ischemic stroke.早期梗死灶扩大可预测缺血性卒中的长期临床结局。
J Neurol Sci. 2014 Dec 15;347(1-2):205-9. doi: 10.1016/j.jns.2014.09.048. Epub 2014 Oct 2.
7
Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.循环CD133+CD34+祖细胞与血浆基质细胞衍生因子-1α:对缺血性中风患者的预测作用
J Stroke Cerebrovasc Dis. 2015 Feb;24(2):319-26. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.026. Epub 2014 Nov 22.
8
The association between circulating endothelial progenitor cells and outcome in different subtypes of acute ischemic stroke.循环内皮祖细胞与不同类型急性缺血性脑卒中患者预后的关系。
Clin Chim Acta. 2014 Jan 1;427:6-10. doi: 10.1016/j.cca.2013.09.029. Epub 2013 Sep 27.
9
Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.基线磁共振成像(MRI)表观扩散系数病变体积对缺血性卒中功能结局的影响。
Neurol Res. 2011 Jun;33(5):494-502. doi: 10.1179/016164111X13007856084124.
10
Increased circulating endothelial progenitor cells in patients with haemorrhagic and ischaemic stroke: the role of endothelin-1.出血性和缺血性脑卒中患者循环内皮祖细胞增加:内皮素-1 的作用。
J Neurol Sci. 2013 Feb 15;325(1-2):90-9. doi: 10.1016/j.jns.2012.12.005. Epub 2013 Jan 3.

引用本文的文献

1
Blood Progenitor Cell Mobilization Driven by TWEAK Promotes Neovascularization and Reduces Brain Damage in a Rat Model of Intracerebral Hemorrhage.肿瘤坏死因子样弱凋亡诱导因子驱动的血液祖细胞动员促进脑出血大鼠模型中的新生血管形成并减轻脑损伤。
Antioxidants (Basel). 2025 May 16;14(5):601. doi: 10.3390/antiox14050601.
2
Endothelial progenitor cells and cerebral small vessel disease in carriers.携带者中的内皮祖细胞与脑小血管病
Cereb Circ Cogn Behav. 2025 Feb 11;8:100378. doi: 10.1016/j.cccb.2025.100378. eCollection 2025.
3
Bioactive Materials Facilitate the Restoration of Neurological Function Post Cerebral Ischemic Stroke.
生物活性材料促进脑缺血性中风后神经功能的恢复。
Int J Nanomedicine. 2024 Dec 31;19:14171-14191. doi: 10.2147/IJN.S493987. eCollection 2024.
4
Understanding Endothelial Dysfunction and Its Role in Ischemic Stroke After the Outbreak of Recanalization Therapies.理解血管内皮功能障碍及其在再通治疗后缺血性卒中的作用。
Int J Mol Sci. 2024 Oct 29;25(21):11631. doi: 10.3390/ijms252111631.
5
The Cerebrovascular Side of Plasticity: Microvascular Architecture across Health and Neurodegenerative and Vascular Diseases.可塑性的脑血管方面:健康、神经退行性疾病和血管疾病中的微血管结构
Brain Sci. 2024 Sep 28;14(10):983. doi: 10.3390/brainsci14100983.
6
Mediterranean Diet Prior to Ischemic Stroke and Potential Circulating Mediators of Favorable Outcomes.地中海饮食对缺血性脑卒中的影响及对有利结局的潜在循环介质。
Nutrients. 2024 Sep 23;16(18):3218. doi: 10.3390/nu16183218.
7
High-Volume Hospital Had Lower Mortality of Severe Intracerebral Hemorrhage Patients.高容量医院中重症脑出血患者的死亡率较低。
J Korean Neurosurg Soc. 2024 Nov;67(6):622-636. doi: 10.3340/jkns.2023.0205. Epub 2024 Mar 4.
8
Neuroprotection Afforded by an Enriched Mediterranean-like Diet Is Modified by Exercise in a Rat Male Model of Cerebral Ischemia.在雄性大鼠脑缺血模型中,运动对富含类地中海饮食所提供的神经保护作用产生影响。
Antioxidants (Basel). 2024 Jan 23;13(2):138. doi: 10.3390/antiox13020138.
9
Biomarkers Assessing Endothelial Dysfunction in Alzheimer's Disease.评估阿尔茨海默病患者血管内皮功能障碍的生物标志物。
Cells. 2023 Mar 22;12(6):962. doi: 10.3390/cells12060962.
10
Endothelial Progenitor Cells in Neurovascular Disorders-A Comprehensive Overview of the Current State of Knowledge.神经血管疾病中的内皮祖细胞——当前知识状态的全面概述
Biomedicines. 2022 Oct 18;10(10):2616. doi: 10.3390/biomedicines10102616.